Market Overview

40 Stocks Moving In Tuesday's Mid-Day Session

Share:

Gainers

  • Moneygram International Inc (NASDAQ: MGI) shares jumped 98.6% to $2.88 after the company reported a strategic partnership with Ripple. Blockchain payments firm Ripple has made an investment in MoneyGram and will also allow the group to use its XRP cryptocurrency as part of the cross-border payments process. Ripple made an initial investment of $30 million in the money transfer company, made up of common stock and a warrant to purchase common stock. Ripple purchased newly-issued common stock including the shares underlying the warrant from MoneyGram at $4.10 per share.
  • Moxian, Inc. (NASDAQ: MOXC) gained 35.4% to $3.1543.
  • G1 Therapeutics, Inc. (NASDAQ: GTHX) surged 23.8% to $24.45 after the company announced Phase 2 trial of Trilaciclib in combination with Chemotherapy showed statistically significant improvement in overall survival in women with metastatic triple negative breast cancer.
  • Immuron Limited (NASDAQ: IMRN) shares jumped 18.4% to $3.03.
  • Lonestar Resources US Inc. (NASDAQ: LONE) gained 17.5% to $2.9250.
  • SunPower Corporation (NASDAQ: SPWR) rose 15.7% to $9.59. Goldman Sachs upgraded SunPower from Neutral to Buy.
  • Telephone and Data Systems, Inc. (NYSE: TDS) gained 13.6% to $33.20 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight.
  • United States Cellular Corporation (NYSE: USM) rose 13% to $49.92 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight.
  • Biocept, Inc. (NASDAQ: BIOC) rose 10.8% to $1.13 after the company announced the commercial launch of its Target Selector NGS Breast Panel, its multi-gene liquid biopsy panel specifically developed for breast cancer.
  • TimkenSteel Corporation (NYSE: TMST) gained 9.5% to $7.72.
  • Jupai Holdings Limited (NYSE: JP) shares rose 9.4% to $2.44.
  • Cesca Therapeutics Inc. (NASDAQ: KOOL) gained 9.3% to $3.05 after the company's subsidiary, ThermoGenesis, received Health Canada approval for its next generation AXP II System for cord blood processing.
  • ACM Research, Inc. (NASDAQ: ACMR) rose 9.1% to $18.25 after highlighting strategic plan to extend access to China's capital markets.
  • Intrexon Corporation (NASDAQ: XON) climbed 8.9% to $8.27 after the company reported a $100 million partnership with Surterra to advance commercial scale fermentation-based cannabinoid production.
  • Renewable Energy Group, Inc. (NASDAQ: REGI) gained 8.5% to $15.53.
  • Carvana Co. (NYSE: CVNA) shares rose 8.3% to $68.93.
  • Hovnanian Enterprises, Inc. (NYSE: HOV) gained 8.3% to $8.05.
  • Nabors Industries Ltd. (NYSE: NBR) shares surged 8.2% to $2.1850.
  • Ocular Therapeutix, Inc. (NASDAQ: OCUL) gained 7.8% to $4.54.
  • Snap Inc (NYSE: SNAP) rose 6.8% to $14.47 after BTIG raised price target on stock from $15 to $20.
  • Beyond Meat, Inc. (NASDAQ: BYND) rose 6.6% to $181.23 after surging 12.20% on Monday.
  • Sunrun Inc. (NASDAQ: RUN) rose 5.3% to $17.99. Goldman Sachs upgraded Sunrun from Neutral to Buy and announced a $20 price target.
  • PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) rose 4.8% to $12.86 after the company reported preliminary results from its Phase 2a clinical trial of PB2452. Statistically significant reversal of ticagrelor was achieved within 5 minutes of initiation.
  • Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) rose 4.6% to $10.97 after the company announced a breakthrough therapy designation granted by the FDA for avexitide for treatment of post-bariatric hypoglycemia.
  • Parsons Corporation (NYSE: PSN) shares rose 3.3% to $32.36 after reporting strong Q1 sales.

Check out these big penny stock gainers and losers

Losers

  • Digital Ally, Inc. (NASDAQ: DGLY) shares tumbled 42.8% to $1.6592. Axon Enterprise Inc (NASDAQ: AAXN) reported the U.S. District Court for the District of Kansas has granted summary judgment in favor of the company stating that Axon's Signal technology does not infringe Digital Ally's 452 patent. The court entered judgment for Axon and dismissed the case in its entirety.
  • ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) declined 38.5% to $5.97 after the company reported a 2.6 million unit offering priced at $6 per unit.
  • Rockwell Medical, Inc. (NASDAQ: RMTI) shares dipped 27.4% to $3.20 after the company priced its 5.83 million share offering at $3 per share.
  • Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) fell 26.8% to $42.01 after the company reported proposed public $300 million offering of common shares.
  • Senmiao Technology Limited (NASDAQ: AIHS) dropped 26.1% to $3.39 after the company reported entry into agreements for registered direct public offering of $6.0 million of common stock and warrants.
  • Vislink Technologies, Inc. (NASDAQ: VISL) shares fell 18.8% to $1.745.
  • Unity Biotechnology, Inc. (NASDAQ: UBX) dipped 14.1% to $7.88 after the company reported topline data for Phase 1 in the first in human study of UBX0101 in patients with Osteoarthritis of the knee.
  • GCP Applied Technologies Inc. (NYSE: GCP) fell 13.2% to $22.90.
  • Precipio, Inc. (NASDAQ: PRPO) dropped 11.8% to $2.84 after falling 21.08% on Monday.
  • Calithera Biosciences, Inc. (NASDAQ: CALA) fell 10.5% to $5.19 after the company reported a common stock offering of 10 million shares.
  • MOGU Inc. (NYSE: MOGU) fell 9.1% to $3.19.
  • Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR) shares dropped 8.4% to $11.40.
  • Hemispherx Biopharma, Inc. (NYSE: HEB) fell 7% to $4.4682 after dropping 5.51% on Monday.
  • 22nd Century Group, Inc. (NYSE: XXII) shares dropped 6.5% to $2.03.
  • Ashford Hospitality Trust, Inc. (NYSE: AHT) dipped 6.3% to $3.27.

Posted-In: Cryptocurrency News Movers & Shakers Intraday Update Markets Movers Trading Ideas General

 

Related Articles (ACMR + AAXN)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Google To Invest Additional $1B In Housing In The Bay Area

Halo Labs Enters Africa Cannabis Market Through Bophelo Acquisition